The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Brister Mark since 2006.
The trader's CIK number is 1323223.
At the time of the last reporting, Brister Mark was the VP Advanced Developm of Obalon Therapeutics Inc. (stock ticker symbol OBLN).
Also see all insider trading activities at Obalon Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | DXCM | 0 | $0 | 50,000 | $1,200,000 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | OBLN | 5,000 | $20,000 | 0 | $0 | 0 | $0 |
2. Obalon Therapeutics Inc (OBLN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-05-02 | DXCM | Sale | 50,000 | 24.00 | 1,200,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-08-06 | OBLN | Buy | 5,000 | 4.00 | 20,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brister Mark (VP Advanced Developm of Obalon Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.